Trinity Biotech Income Statement (2009-2025) | TRIB

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Jun2025	Dec2025
Revenue & cost
Revenue (Quarter)	32.01M	32.77M	25.59M	25.84M	22.00M	19.52M	15.68M	15.42M	15.70M	15.72M	14.83M	13.90M	14.68M	13.43M	14.70M	15.84M	15.15M	15.86M
Cost of Revenue (Quarter)	15.24M	17.11M	14.68M	14.82M	13.10M	12.29M	9.69M	9.84M	15.38M	10.35M	9.26M	8.87M	10.40M	8.86M	9.18M	10.11M	9.84M	10.98M
Gross Profit (Quarter)	16.78M	15.66M	10.91M	11.03M	8.90M	7.24M	5.98M	5.58M	0.33M	5.38M	5.57M	5.03M	4.28M	4.57M	5.52M	5.73M	5.31M	4.88M
Operating items
Research & Development (Quarter)	-1.26M	-1.28M	-1.44M	-1.06M	-1.06M	-0.94M	-0.96M	-0.98M	-1.02M	-1.17M	-0.86M	-1.23M	-1.17M	-1.12M	-1.09M	-0.99M	-1.01M	-1.45M
Share-based Compensation (IS) (Quarter)				312.00		0.15M		122.00	0.12M	1.32M			0.74M	-1.01M			250.00	0.14M
Selling, General & Administrative (Quarter)	-6.27M	-6.87M	-6.02M	-6.59M	-6.11M	-5.58M	-6.23M	-5.93M	-5.15M	-9.68M	-8.63M	-7.91M	-7.68M	-6.94M	-7.50M	-6.42M	-6.52M	-8.37M
Restructuring Costs (Quarter)																	339.00
Other Operating Expenses (Quarter)														12.86M
Operating Expenses (Quarter)	-7.54M	-8.16M	-7.46M	-7.65M	-7.17M	-6.52M	-7.20M	-6.91M	-6.17M	-10.84M	-9.49M	-9.14M	-8.85M	-8.06M	-8.59M	-7.41M	-7.53M	-9.82M
Operating Income (Quarter)	9.09M	9.07M	3.08M	0.22M	2.77M	0.56M	-1.22M	-1.85M	-8.13M	-8.16M	-3.92M	-14.85M	-4.50M	-3.78M	-3.04M	-4.05M	-2.56M	-11.51M
EBIT (Quarter)	9.09M	9.07M	3.08M	0.22M	2.77M	0.56M	-1.22M	-1.85M	-8.13M	-8.16M	-3.92M	-14.85M	-4.50M	-3.78M	-3.04M	-4.05M	-2.56M	-11.51M
Non-operating items
Interest & Investment Income (Quarter)
Non Operating Income (Quarter)					-1.17M		-12.00M	-8.30M	-1.85M		-2.40M	-3.76M	-2.00M	-1.73M	209.00	-2.84M	-2.24M	6.45M
Net income details
EBT (Quarter)	10.30M	10.29M	4.29M	-0.13M	1.60M	-2.43M	-13.22M	-10.15M	-9.99M	-10.43M	-6.32M	-18.61M	-6.50M	-5.50M	-3.25M	-6.89M	-4.79M	-15.80M
Tax Provisions (Quarter)	-0.39M	-0.07M	-0.10M	-0.66M	-0.25M	0.94M			-0.00M	0.01M	0.01M	-0.29M	-0.22M	-0.12M	-0.07M	0.00M
Profit After Tax (Quarter)	7.33M	-10.02M	4.39M	0.53M	1.32M	-1.26M	-13.22M	-10.15M	-8.95M	-10.08M	-0.01M	11.80M	-6.72M	-5.50M	-0.00M	-10.07M	-4.79M	-16.95M
Income from Continuing Operations (Quarter)	10.69M	10.36M	4.39M	0.53M	1.85M	-3.37M	-13.22M	-10.15M	-9.98M	-10.44M	-6.33M	-18.32M	-6.28M	-5.39M	-3.18M	-6.89M	-4.79M	-15.80M
Consolidated Net Income (Quarter)	10.69M	10.36M	4.39M	0.53M	1.85M	-3.37M	-13.22M	-10.15M	-9.98M	-10.44M	-6.33M	-18.32M	-6.28M	-5.39M	-3.18M	-6.89M	-4.79M	-15.80M
Income towards Parent Company (Quarter)	10.69M	10.36M	4.39M	-783.00	1.85M	-3.37M	-13.22M	-0.01M	-9.98M	-10.44M	-6.33M	-18.32M	-6.28M	-5.39M	-3.18M	-6.89M	-4.79M	-15.80M
Net Income towards Common Stockholders (Quarter)	10.69M	10.36M	4.39M	-783.00	1.85M	-3.37M	-13.22M	-0.01M	-9.98M	-10.44M	-6.33M	-18.32M	-6.28M	-5.39M	-3.18M	-6.89M	-4.79M	-15.80M
Additional items
EPS (Basic) (Quarter)	0.01	0.12	0.00	0.00	0.00	-0.04	-0.01	0.00	-0.01	-0.08	0.00	-0.01	0.00	-0.04	0.00	0.00	0.00	-0.04
EPS (Weighted Average and Diluted) (Quarter)				-19.58				-51.08
Shares Outstanding (Weighted Average) (Quarter)	1,213.00M	83.61M	1,213.00M	1,213.00M	1,213.00M	83.61M	1,445.00M	1,963.00M	1,963.00M	134.94M	1,967.00M	1,972.00M	1,972.00M	153.10M	2,338.00M	2,338.00M	2,377.00M	359.19M	4,337.00M	371.51M
Shares Outstanding (Diluted Average) (Quarter)				40.00				190.00
EBITDA (Quarter)	9.09M	9.07M	3.08M	0.22M	2.77M	0.56M	-1.22M	-1.85M	-8.13M	-8.16M	-3.92M	-14.85M	-4.50M	-3.78M	-3.04M	-4.05M	-2.56M	-11.51M
Interest Expenses (Quarter)	-1.22M	-1.22M	-1.21M	-1.36M	-1.36M	-3.00M	-12.22M	-8.30M	-2.18M	-2.38M	-2.55M	-3.82M	-2.39M	-2.34M	-0.26M	-2.84M		-3.38M
Tax Rate (Quarter)	-3.76%	-0.69%	-2.45%	511.72%	-15.68%	-38.59%			0.02%	-0.12%	-0.17%	1.55%	3.42%	2.09%	2.06%	-0.04%

Research Tools

Trinity Biotech Income Statement (2009-2025) | TRIB

Create an account

Sign In

Reset Password